Avoro Capital Advisors LLC Cue Biopharma, Inc. Transaction History

Avoro Capital Advisors LLC

  • $8.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$11.2 - $16.09 $5.07 Million - $7.28 Million
-452,500 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$11.12 - $16.4 $15.8 Million - $23.2 Million
-1,417,500 Reduced 75.8%
452,500 $5.66 Million
Q4 2019

Feb 14, 2020
BUY
$7.06 - $17.47 $13.2 Million - $32.7 Million
1,870,000 New
1,870,000 $29.7 Million

Others Institutions Holding CUE

# of Institutions
78
Shares Held
16.3M
Call Options Held
12.9K
Put Options Held
39.1K
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $43.9M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email